Tramadol extended-release formulations in the management of pain due to osteoarthritis

References

• Goodwin JL, Kraemer JJ, Bajwa ZH. The use of opioids in the treatment of osteoarthritis: when, why, and how? Curr. Pain Headache Rep.9(6), 390–398 (2005).
   PubMedGoogle Scholar
• Schnitzer TJ. Update on guidelines for the treatment of chronic musculoskeletal pain. Clin. Rheumatol.25(Suppl. 1), 22–29 (2006).
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the Medical Management of Osteoarthritis of the Hip and Knee: 2000 Update. Arthritis Rheum.43(9), 1905–1915 (2000).
   PubMed Web of Science ®Google Scholar
• Jordan KM, Arden NK, Doherty M et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheum. Dis.62(12), 1145–1155 (2003).
   PubMed Web of Science ®Google Scholar
• American Pain Society guideline for treatment of arthritis pain. J. Pain Palliat. Care Pharmacother.16(4), 130–132 (2002).
   PubMedGoogle Scholar
• Hair PI, Curran MP, Keam SJ. Tramadol extended-release tablets. Drugs66(15), 2017–2027; discussion 2028–2030 (2006).
   PubMed Web of Science ®Google Scholar
• Adler L, McDonald C, O’Brien C, Wilson M. A comparison of once-daily tramadol with normal release tramadol in the treatment of pain in osteoarthritis. J. Rheumatol.29(10), 2196–2199 (2002).
   PubMed Web of Science ®Google Scholar
• Babul N, Noveck R, Chipman H et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J. Pain Symptom Manage.28(1), 59–71 (2004).
   PubMed Web of Science ®Google Scholar
• Burch F, Fishman R, Messina N et al. A comparison of the analgesic efficacy of tramadol contramid OAD vs placebo in patients with pain due to osteoarthritis. J. Pain Symptom Manage.34(3), 328–338 (2007).
   PubMed Web of Science ®Google Scholar
• Keating GM. Tramadol sustained- release capsules. Drugs66(2), 223–230 (2006).
   PubMedGoogle Scholar
• Malonne H, Coffiner M, Fontaine D et al. Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain. J. Clin. Pharm. Ther.30(2), 113–120 (2005).
   PubMed Web of Science ®Google Scholar
• Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Clin. Ther.26(11), 1774–1782 (2004).
   PubMed Web of Science ®Google Scholar
• Hernandez-Lopez C, Martinez-Farnos L, Karhu D et al. Comparative bioavailability between two tramadol once-daily oral formulations. Methods Find. Exp. Clin. Pharmacol.28(6), 373–378 (2006).
   PubMed Web of Science ®Google Scholar
• Lee CR, McTavish D, Sorkin EM. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs46(2), 313–340 (1993).
   PubMed Web of Science ®Google Scholar
• Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin. Pharmacokinet.43(13), 879–923 (2004).
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther.23(8), 1296–1310 (2001).
   PubMed Web of Science ®Google Scholar
• Bodalia B, McDonald CJ, Smith KJ, O’Brien C, Cousens L. A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules. J. Pain Symptom Manage.25(2), 142–149 (2003).
   PubMed Web of Science ®Google Scholar
• Mongin G, Yakusevich V, Köpe A et al. Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: a randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee. Clin. Drug Invest.24(9), 545–558 (2004).
   PubMed Web of Science ®Google Scholar
• Gana TJ, Pascual ML, Fleming RR et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr. Med. Res. Opin.22(7), 1391–1401 (2006).
   PubMed Web of Science ®Google Scholar
• Fishman RL, Kistler CJ, Ellerbusch MT et al. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid® OAD). J. Opioid Management (2007) (In Press).
   PubMedGoogle Scholar
• Mattia C, Coluzzi F. Once-daily tramadol in rheumatological pain. Expert Opin. Pharmacother.7(13), 1811–1823 (2006).
   PubMed Web of Science ®Google Scholar
• Malonne H, Sonet B, Streel B et al. Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol. Br. J. Clin. Pharmacol.57(3), 270–278 (2003).
   Google Scholar
• Karhu D, Bouchard S. Pharmacokinetic evaluation of a novel once-a-day tramadol hydrochloride formulation. Presented at: American College of Clinical Pharmacology (ACCP) Annual Meeting. Rockville, USA, 11–13 September 2005 (Poster 14).
   Google Scholar
• Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech.4(3), E31 (2003).
   PubMedGoogle Scholar
• Hair PI, Curran MP, Keam SJ. Tramadol extended-release tablets in moderate to moderately severe chronic pain in adults: profile report. CNS Drugs21(3), 259–263 (2007).
   PubMedGoogle Scholar
• SRL Ultram® Extended-Release Tablets, prescribing information. Biovail Laboratories International, ON, Canada (2005).
   Google Scholar
• Lenaerts V, Moussa I, Dumoulin Y et al. Cross-linked high amylose starch for controlled release of drugs: recent advances. J. Control. Release53(1–3), 225–234 (1998).
   PubMed Web of Science ®Google Scholar
• Hancock BC, Carlson GT, Ladipo DD, Langdon BA, Mullarney MP. The powder flow and compact mechanical properties of two recently developed matrix-forming polymers. J. Pharm. Pharmacol.53(9), 1193–1199 (2001).
   PubMed Web of Science ®Google Scholar
• Radulescu F, Sarbu A, Stroescu S et al. Long-term safety, tramadol contramid® OAD in pain treatment. Presented at: The 17th Annual clinical meeting of the American Academy of Pain Management. Orlando, FL, USA, 7 September 2006.
   Google Scholar
• Karhu D, Bouchard S. Comparative bioavailability of tramadol contramid® once-a-day and tramadol immediate-release tablets. Presented at: The American Academy of Pain Medicine, 23rd Annual Meeting. New Orleans, LA, USA, 7–10 February 2007 (Poster 145).
   Google Scholar
• International Conference on Harmonisation of the Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Guideline for Industry: the extent of population exposure to assess clinical safety: for drugs intended for long term treatment of non-life-threatening conditions.
   Google Scholar
• Burch F, Fishman R, Hunt T et al. Safety data for tramadol Contramid® OAD in treatment of pain. Presented at: The 17th Annual clinical meeting of the American Academy of Pain Management. Orlando, FL, USA, 7–9 September 2006.
   Google Scholar
• Mattia C, Coluzzi F. COX-2 inhibitors: pharmacological data and adverse effects. Minerva Anestesiol.71(7–8), 461–470 (2005).
   PubMedGoogle Scholar
• Katz WA, Rothenberg R. Section 4: treating the patient in pain. J. Clin. Rheumatol.11(Suppl. 2), S16–S27, discussion S27–S28 (2005).
   Google Scholar
• Lai JC, Sista S, Eradiri O. The pharmacokinetics of novel once daily tramadol hydrochloride extended release tablets in healthy subjects. Presented at: Annual Meeting of the American Association of Pharmaceutical Scientists. Salt Lake City, UT, USA, 26–30 October 2003 (Abstract M1071).
   Google Scholar
• Bond MJ, Breivik H: Why pain control matters in a world full of killer diseases. Pain: Clinical Updates12(4), 1–4 (2004).
   Google Scholar
• Gibson S. Older people’s pain. Pain: Clinical updates14(3), 1–4 (2006).
   Google Scholar
• Helme RD Gibson SJ. The epidemiology of pain in elderly people. Clin. Geriatr. Med.17(3), 417–431 (2001).
   PubMed Web of Science ®Google Scholar